Liangping Xia
9PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|May 25, 2024
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer.Lin Yang, Jiahong Yi, Wenzhuo He
|Sep 04, 2023
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy.Chenran Wang, Maohua Huang, Yuning Lin
|Nov 14, 2022
Regorafenib with or without a programmed cell death protein 1 antibody as third-line treatment for microsatellite stable metastatic colorectal cancer.Wen-Zhuo He, Lei Wang, Chen-Xi Yin
|Nov 06, 2021
Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer.Yuan-Zhong Yang, Wan-Ming Hu, Liang-Ping Xia
|Jan 29, 2021
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis.Yafei You, Chang Jiang, Kunwei Peng
|May 24, 2020
Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1.Jinye Xie, Liangping Xia, Wei Xiang
Pageof 2
Frequent Collaborators
4 joint publications
Wenzhuo He
2 joint publications
Zhenchong Xiong
2 joint publications
Lin Yang
1 joint publications
Rui-Hua Xu
1 joint publications
Dan Xie
1 joint publications
Wan-Ming Hu
1 joint publications
Lei Wang
1 joint publications
Ya-Nan Jin
1 joint publications
Gui-Fang Guo
1 joint publications
Jinye Xie
